tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BGNE Stock Latest News

BeiGene price target raised to $236 from $235 at TD Cowen
The FlyBeiGene price target raised to $236 from $235 at TD Cowen
2d ago
NVS
BGNE
BeiGene receives European Commission approval for tislelizumab
PremiumThe Fly
BeiGene receives European Commission approval for tislelizumab
3d ago
BGNE
Drugmakers look to alternative suppliers after draft U.S. legislation, FT says
PremiumThe Fly
Drugmakers look to alternative suppliers after draft U.S. legislation, FT says
15d ago
LLY
AVBP
BeiGene price target lowered to $164.30 from $179.30 at BofA
PremiumThe Fly
BeiGene price target lowered to $164.30 from $179.30 at BofA
18d ago
BGNE
BeiGene price target lowered to $161 from $196 at Bernstein
PremiumThe Fly
BeiGene price target lowered to $161 from $196 at Bernstein
30d ago
BGNE
BeiGene price target lowered to $161 from $196 at Bernstein
PremiumThe FlyBeiGene price target lowered to $161 from $196 at Bernstein
1M ago
BGNE
BeiGene Announces Executive Team Reshuffle and Director Pay Revision
PremiumCompany Announcements
BeiGene Announces Executive Team Reshuffle and Director Pay Revision
1M ago
8K
BGNE
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
1M ago
AZN
BMY
BeiGene receives FDA approval for Tevimbra
PremiumThe Fly
BeiGene receives FDA approval for Tevimbra
1M ago
BGNE
BeiGene gets approval for Tevimbra BLA
PremiumThe Fly
BeiGene gets approval for Tevimbra BLA
1M ago
BGNE
BeiGene announces first doses of Brukinsa administered
PremiumThe Fly
BeiGene announces first doses of Brukinsa administered
1M ago
BGNE
BeiGene announces FDA accelerated approval of BRUKINSA
PremiumThe Fly
BeiGene announces FDA accelerated approval of BRUKINSA
2M ago
BGNE
BeiGene announces new efficacy analysis comparing Brukinsa vs. Acalabrutinib
PremiumThe FlyBeiGene announces new efficacy analysis comparing Brukinsa vs. Acalabrutinib
2M ago
BGNE
BeiGene price target lowered to $345 from $350 at Guggenheim
PremiumThe Fly
BeiGene price target lowered to $345 from $350 at Guggenheim
2M ago
BGNE
BeiGene price target raised to $235 from $224 at TD Cowen
PremiumThe Fly
BeiGene price target raised to $235 from $224 at TD Cowen
2M ago
BGNE
BeiGene’s Biologics License Application for tevimbra accepted by FDA
PremiumThe Fly
BeiGene’s Biologics License Application for tevimbra accepted by FDA
2M ago
BGNE
BeiGene, Ltd.’s New Technology Risk – A Cause for Worry?
PremiumCompany Announcements
BeiGene, Ltd.’s New Technology Risk – A Cause for Worry?
2M ago
BGNE
BeiGene reports Q4 EPS ($3.53), consensus ($3.73)
PremiumThe Fly
BeiGene reports Q4 EPS ($3.53), consensus ($3.73)
2M ago
BGNE
BeiGene receives CHMP opinion recommending approval of tislelizumab
PremiumThe Fly
BeiGene receives CHMP opinion recommending approval of tislelizumab
2M ago
BGNE
BGNE Earnings this Week: How Will it Perform?
PremiumPre-EarningsBGNE Earnings this Week: How Will it Perform?
2M ago
BGNE
BeiGene price target lowered to $163 from $200 at BofA
PremiumThe Fly
BeiGene price target lowered to $163 from $200 at BofA
2M ago
BGNE
BeiGene assumed with an Overweight at JPMorgan
PremiumThe Fly
BeiGene assumed with an Overweight at JPMorgan
3M ago
BGNE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >